Current Analysis

Genmab (GMAB)

MarketCap: 26,926,582,789
Sector: Biotechnology

Open: 40.0 Close: 43.79 Change: 9.47%

For investors tracking the biotech battleground, the question looms large: what cosmic event propelled Genmab (GMAB) into a near double-digit surge, reinforcing its stable uptrend? Yesterday, the Danish biotechnology titan, Genmab, announced a significant clinical breakthrough that sent its shares soaring. The company reported positive top-line results from its global Phase 3…

Sentiment Value: 0.89

...
... ...